- Quotes
- Dashboard
- Chart
- Historical Prices
- Options
- News & PR
- News
- Market Currents
- Press Releases
- Coverage
- Cramer
- Top Analysts
- Business Intelligence
- Transcripts
- Events
- Key Developments
- Earnings
- History & Projected
- Consensus
- Peer Earnings
- Filings
- SEC Filings
- Annual Report
- Financials
- Income Statement
- Balance Sheet
- Cash Flow
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
SHPGY Market Currents
more »
-
April 26 Shire Pharmaceuticals (SHPGY): Q1 EPS of $1.24 may not be comparable to consensus of $0.52. Revenue of $1.17B (+20.6% Y/Y). Shares +1.7% premarket. (PR)
Comment![Earnings, Healthcare, On the Move]
SHPGY in Focus
more »
SHPGY Related Articles
more »
SHPGY News
more »
-
at MarketWatch.com (Mar 15, 2012)
-
at MarketWatch.com (Nov 30, 2011)
-
at MarketWatch.com (May 31, 2011)
-
at MarketWatch.com (May 26, 2011)
-
at MarketWatch.com (May 18, 2011)
SHPGY Press Releases and Filings
more »
Currently, there are no press releases or filings on SHPGY.
SHPGY Latest Transcript
more »
-
Thu, Apr 26
SHPGY Cramer
more »
-
Thu, Jul 27, 2006
SHPGY Instablog posts
more »
SHPGY vs. ETF Alternatives
Company Description
Currently, there's no company description for SHPGY.
